TAPAZOLE
- Product NDC
- 60793-104
- 11-digit product format
- 607930104
- Labeler code
- 60793
- Product ID
- 60793-104_5ccf98b1-7cf7-47da-893d-80d0e14493e7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- methimazole
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Application
- ANDA040320
- Marketing category
- ANDA
- Marketing start
- 2000-03-31
- Marketing end
- 0000-00-00
- Substance
- METHIMAZOLE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Thyroid Hormone Synthesis Inhibitor [EPC],Thyroid Hormone Synthesis Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60793-104-01 | 60793010401 | 100 TABLET in 1 BOTTLE (60793-104-01) | 100 tablet | 2000-03-31 | 0000-00-00 | No | No | Current |